Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia

Anti-Cancer Drugs

Volumn 8, Issue 7, 1997, Pages 662-665

  Volm, M ^a   Stammler, G ^a   Zintl, F ^b   Koomagi R ^a   Sauerbrey, A ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Childhood acute lymphoblastic leukemia; Immunocytochemistry; Lung resistance related protein; Prognostic value

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; MEMBRANE PROTEIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RELAPSE; STATISTICS;

CHILD; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, MULTIPLE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; NEOPLASM PROTEINS; PROGNOSIS; RECURRENCE; SURVIVAL RATE; TIME FACTORS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0030824146     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199708000-00003     Document Type: Article

References (17)

1. Sauerbrey A, Zintl F, Volm M. P-glycoprotein and glutathione S-transferase in childhood acute lymphoblastic leukemia. Br J Cancer 1994; 70: 1144-9.
2. Volm M, Zintl F, Edler L, Sauerbrey A. Prognostic value of protein kinase C. proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1997; 28: 117-26.
3. Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a 110 kD vesicular protein in non-P-glycoprotein mediated multidrug-resistance. Cancer Res 1993; 53: 1475-9.
4. Futscher BW, Abbaszadegan MR, Domann F, Dalton WS. Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem Pharmacol 1994; 47: 1601-6.
5. Izquierdo MA, Shoemaker RH, Flens MJ, et al. Overlapping phenotypes of multidrug resistance among panels of human cancer cell lines. Int J Cancer 1996; 65: 230-7.
6. Izquierdo MA, Scheffer GL, Flens MJ. Expression of the non-P-glycoprotein multidrug-resistance associated protein LRP in normal human tissues and tumors. Am J Pathol 1996; 148: 877-87.
7. List AF, Spier CS, Grogan TM, Johnson C, et al. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 1996; 87: 2464-9.
8. Bennett JM, Catovsky D, Daniel MT, et al. French-American-British (FAB) cooperative group. Proposal for the classification of the acute leukaemias. Br J Haematol 1976; 33: 451-8.
9. Zintl F, Malke H, Reimann M, et al. Results with randomized BFM adopted studies for ALL therapy in childhood in East German countries. In: Büchner G, Schellong W, Hiddemann J, Urbanitz J, Ritter J, eds. Acute leukemias IV: prognostic factors. Berlin: Springer 1993: 179-86.
10. Sauerbrey A, Zintl F, Malke H, et al. Results and expression with a modified BFM-protocol for the treatment of relapsed childhood acute lymphoblastic leukemia in East Germany. Kinische Pädiatrie 1993; 205: 281-4.
11. Volm M, Sauerbrey A, Zintl F. Prognostic significance of protein kinase C in newly diagnosed childhood acute lymphoblastic leukemia. Int J Oncol 1994; 4: 363-8.
12. Volm M, Sauerbrey A, Stammler G, Zintl F. Detection of Fos, Jun and Ras in newly diagnosed childhood acute lymphoblastic leukemia by immunocytochemistry and PCR Int J Oncol 1994; 14: 1251-6.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Ass 1956; 53: 457-81.
14. Fleiss JL, ed. Statistical methods for rates and proportion. New York: John Wiley 1973.
15. Izquierdo MA, van der Zee AGJ, Vermorken JB, et al. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst 1995; 87: 1230-7.
16. Chugani DC, Rome LH, Kedersha NL. Evidence that vault ribonucleoprotein particles localize to the nuclear pore comples. J Cell Sci 1993; 106: 23-9.
17. Schadendorf D, Makki A, Stahr C, et al. Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 1995; 147: 1545-52.